From the very beginning of her research, Eleanor had been focused on one objective: to break free from their dependency on Vanessa as the sole donor.
She would rather pour a hundred times more effort into her work than ever have to beg someone for help in the future.
In addition to Serena Goodwin''s treatment, she initiated a separate research project. Using her own blood samples, she began searching for a unique antibody reaction that might exist among direct rtives.
The idea hadn''te out of nowhere; it had taken root the moment she learned her daughter might inherit the disease. As a mother, she couldn''t ept a future where her daughter''s life depended on an outsider like Vanessa-a woman with impure motives who could use her life as a threat at any moment. Ian had chosen topromise and y her game. Eleanor couldn''t. Her choice was to shatter the foundation of their reliance on herpletely.
Combining Dr. Smith''s experimental data with theories published by hematology experts worldwide, Eleanor was confident she could find the answer. She began byparing early samples from Serena and Gina.
She formed a hypothesis: if the disease could be passed down through genes, then perhaps a more subtle, perfectly matched immune response or antibody- generating mechanism existed between direct blood rtives, one that had yet to be discovered.
The theory was already solid in her mind. She knew she was on the right path; she just needed to find the key.
And Serena''s trial was the perfect avenue for her research.
"Dr. Sutton, Miss Goodwin''s new blood samples have been delivered to yourb,"
a nurse said, knocking before entering.
Eleanor snapped out of her thoughts and nodded. "Thank you."
A momentter, she rose and entered theboratory, her hands moving with practiced ease as she operated the equipment to analyze Serena''s blood. She left no stone unturned, leveraging every piece of avable data.
After another failed attempt, she leaned wearily against the instrument table, closing her eyes in thought. Suddenly, a bold idea struck her like a lightning bolt.
"A targeted catalyst," Eleanor murmured. Shaking off her exhaustion, she dove back into her research, guided by her new theory.
"El''s been in theb for two hours and hasn''te out yet," Smith replied.
"Alright. When she does, please let her know I''ll take care of our daughter." "Of course," Smith said.
He walked over to Eleanor''sb and peered through the ss window. Inside, she waspletely
absorbed in her work. A
admiration crossed his face,
ve
followed by a hint of concern She was pushing herself too hard. Could her body handle this kind of pressure? Intensive scientific research took a significant physical toll.
Eleanor pulled out a refrigerated blood sample-she''d lost count of how many extractions she''d
performed. She ced it in a
precision incubator that simted a
pharmaceutical environment,
continuously adjusting the
parameters, trying to cultivate and
stimte a reaction.
After a quick dinner, she was back at it again, possessed by a powerful feeling of inspiration. She had to chase it. She couldn''t stop now.
Around midnight, Smith''s phone rang again. It wasn, his voice low and urgent. "Is she still in there?"
Smith sighed. "I tried to talk her out of it, but El said she has to finish an experiment. She''s noting out."
"Get her out of there,"n ordered, his voice tight with worry. "Whatever experiment it is, she''s not to work on it any longer."
"Alright, I''ll try again, but I can''t promise I can convince her."
"Put her on the phone. Let me talk to her,"n insisted.
Smith pressed the inte button for Eleanor''sb. She stepped away from her work and opened the door.
Just need a little more
IMS
time." .
"El, you can''t keep going like this. The experiments will always be there, but you can''t destroy your health over them."